Introduction/objectives
inflammation, synovial joints, Rheumatoid arthritis, RA, autoimmune disease
RHEUMATOID ARTHRITIS, AUTOIMMUNE DISEASE, INFLAMMATION
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by ongoing inflammation and degradation of synovial joints. The oral JAK inhibitor, upadacitinib, is approved for RA. We conducted an integrated safety analysis of upadacitinib 15 mg once daily (QD) in patients from Latin America (LATAM) versus the rest of the world (RoW).